Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autoimmunity: Rubbing salt in the wound.
Mesenchymal stem cells as treatment for MS - progress to date.
Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis.
Over six cups of coffee a day may reduce the risk of developing multiple sclerosis.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
Multiple sclerosis: a primary care perspective.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Ximino
An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
Validity and reliability of VO2-max measurements in persons with multiple sclerosis.
Noninvasive molecular imaging of neuroinflammation.
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.

Pages